5-ALA does not potentiate dihydroartemisinin against Plasmodium falciparum malaria parasites

Read full text
Authors: Hannah Michaela Behrens, Isabelle G. Henshall, Tobias Spielmann
Cited by: 1
References: 12

Abstract

In this Correspondence, H. Behrens and colleagues show that the potentiating effect of the small molecule 5-aminolaevulinic acid (5-ALA) on the activity of artemisinin observed in cancer does not translate to malaria parasites. Thus, co-administration of artemisinin and 5-ALA does not seem to be a promising strategy to improve malaria treatment.

Fields of Study & Subjects

Malaria Research and Control Biological Research and Disease Studies Pharmacological Effects of Natural Compounds

Publication details

Journal / source
EMBO Molecular Medicine
Publisher
Springer Science and Business Media LLC
Volume
18
Issue
4
Pages
1130–1133
Publication date
27 February 2026
Language
EN